tiprankstipranks
pc:immun

Immunai

180 Varick Street New York, NY, US
https://immunai.com/
Immunai is a biotechnology company that develops single-cell immune profiling and computational platforms to map the human immune system. The company combines high-throughput single-cell assays, multi-omic data integration, and machine-learning analytics to identify immune cell states, biomarkers, and therapeutic targets for drug discovery and translational research partnerships.

Leadership & Board

Current Number of Employees182
Current LinkedIn Followers26,353

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$215M
Total Amount Raised$215M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$215M
Latest Funding Amount$215M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Company Momentum Positive

Articles Published on TipRanks3
Articles Published on TipRanks
3
LinkedIn Trend+0.32% followers
LinkedIn Trend
+0.32% followers
Workforce Trend+1.1% employees
Workforce Trend
+1.1% employees
Immunai LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 27, 2021
Series B
$215.00M

Investors

Investor Name
Funding Round

Related News and Analysis